Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8D51

Parathyroid hormone 1 receptor extracellular domain complexed with a peptide ligand containing beta-3-homotryptophan

Summary for 8D51
Entry DOI10.2210/pdb8d51/pdb
DescriptorParathyroid hormone/parathyroid hormone-related peptide receptor, PTHrP[1-36], 1,2-ETHANEDIOL, ... (5 entities in total)
Functional Keywordsparathyroid hormone 1 receptor, signaling, beta-amino acid, signaling protein
Biological sourceHomo sapiens (human)
More
Total number of polymer chains2
Total formula weight14945.42
Authors
Yu, Z.,Kreitler, D.F.,Gellman, S.H. (deposition date: 2022-06-03, release date: 2023-06-14, Last modification date: 2023-12-27)
Primary citationYu, Z.,Kreitler, D.F.,Chiu, Y.T.T.,Xu, R.,Bruchs, A.T.,Bingman, C.A.,Gellman, S.H.
Harnessing Aromatic-Histidine Interactions through Synergistic Backbone Extension and Side Chain Modification.
Angew.Chem.Int.Ed.Engl., 62:e202308100-e202308100, 2023
Cited by
PubMed Abstract: Peptide engineering efforts have delivered drugs for diverse human diseases. Side chain alteration is among the most common approaches to designing new peptides for specific applications. The peptide backbone can be modified as well, but this strategy has received relatively little attention. Here we show that new and favorable contacts between a His side chain on a target protein and an aromatic side chain on a synthetic peptide ligand can be engineered by rational and coordinated side chain modification and backbone extension. Side chain modification alone was unsuccessful. Binding measurements, high-resolution structural studies and pharmacological outcomes all support the synergy between backbone and side chain modification in engineered ligands of the parathyroid hormone receptor-1, which is targeted by osteoporosis drugs. These results should motivate other structure-based designs featuring coordinated side chain modification and backbone extension to enhance the engagement of peptide ligands with target proteins.
PubMed: 37587780
DOI: 10.1002/anie.202308100
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2 Å)
Structure validation

237735

数据于2025-06-18公开中

PDB statisticsPDBj update infoContact PDBjnumon